ArticleCancers2022

Overall Survival Improvement in Patients with Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer and Bone Metastasis Treated with Denosumab.

How-Wen Ko et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.